Evaluation of Non-Alcoholic Fatty Liver Disease (NAFLD) in Obese Adult Volunteers According to Increasing Insulin Resistance and Loss of Glucose Control.

First published in Current Research in Diabetes & Obesity Journal on 2022 January.
Curre Res Diabetes & Obes J 2022; 15(3): 555914. DOI: 10.19080/CRDOJ.2022.15.555914

Authors: Forst T, Botz I, Berse M, Voswinkel S, Strempler ME, Baumann S, Schultz A

Download full article as Pdf file:

Pdf File

REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board
located at CRS Mannheim

LET’S TALK SCIENCE

+49 621 150 45 – 0

Dr. Marc Hetzel

VP & Head of Business Development
located at CRS Management

LET’S TALK BUSINESS

+49 621 150 45 – 0

Evaluation of Non-Alcoholic Fatty Liver Disease (NAFLD) in Obese Adult Volunteers According to Increasing Insulin Resistance and Loss of Glucose Control.

Read more

REACHING OUT IS EASY AND FAST – LET’S TALK

You May Also Like

Bioequivalence of macitentan and tadalafil given as fixed-dose combination or single-component tablets in healthy subjects.

Midazolam microdosing applied in early clinical development for drug-drug interaction assessment.

The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive – A randomized controlled trial.